Holen Sie sich die Stockscreener-App
4.23
4.56%
0.17
Schlusskurs vom Vortag:
$4.06
Offen:
$4.19
24-Stunden-Volumen:
78,279
Relative Volume:
0.68
Marktkapitalisierung:
$240.25M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-98.43M
KGV:
-1.8077
EPS:
-2.34
Netto-Cashflow:
$-119.33M
1W Leistung:
-6.29%
1M Leistung:
-18.21%
6M Leistung:
+23.04%
1J Leistung:
-44.36%
1-Tages-Spanne:
$4.10
$4.4179
1-Wochen-Bereich:
$4.0207
$4.8398
52-Wochen-Spanne:
$2.9448
$9.70
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Firmenname
Foghorn Therapeutics Inc
Sektor
Branche
Telefon
617-586-3100
Adresse
500 TECHNOLOGY SQUARE, CAMBRIDGE
Vergleichen Sie FHTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.25 | 229.51M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Fortgesetzt | B. Riley Securities | Buy |
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-03 | Eingeleitet | Jefferies | Buy |
| 2024-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2023-03-28 | Eingeleitet | BofA Securities | Buy |
| 2023-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-17 | Eingeleitet | Cowen | Outperform |
| 2020-11-17 | Eingeleitet | Goldman | Buy |
| 2020-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-17 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Foghorn Therapeutics Inc Aktie (FHTX) Neueste Nachrichten
Has Foghorn Therapeutics Inc. formed a bullish divergenceTrade Signal Summary & Verified Stock Trade Ideas - newser.com
What does recent volatility data suggest for Foghorn Therapeutics Inc.Rate Cut & Real-Time Volume Trigger Notifications - newser.com
Foghorn Therapeutics Inc. stock daily chart insightsLong Setup & Fast Exit/Entry Strategy Plans - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.July 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Why Foghorn Therapeutics Inc. stock is rated strong buyTrade Volume Report & Weekly Return Optimization Alerts - newser.com
What institutional flow reveals about Foghorn Therapeutics Inc.Weekly Gains Report & Weekly Return Optimization Alerts - newser.com
Multi asset correlation models including Foghorn Therapeutics Inc.2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Will Foghorn Therapeutics Inc. stock go up soonQuarterly Profit Review & Long-Term Capital Growth Strategies - newser.com
Published on: 2025-10-09 05:14:43 - newser.com
Foghorn Therapeutics (NASDAQ:FHTX) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why Foghorn Therapeutics Inc. stock is seen as undervaluedEntry Point & Safe Entry Zone Tips - newser.com
Using Ichimoku Cloud for Foghorn Therapeutics Inc. technicalsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Chart based exit strategy for Foghorn Therapeutics Inc.Market Risk Report & Verified Technical Trade Signals - newser.com
Detecting price anomalies in Foghorn Therapeutics Inc. with AIOil Prices & Free Technical Pattern Based Buy Signals - newser.com
How to monitor Foghorn Therapeutics Inc. with trend dashboardsMarket Performance Recap & Consistent Profit Alerts - newser.com
Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):